A Study on Factors of Biochemical Response in Autoimmune Hepatitis

NCT06356506 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 630

Last updated 2024-04-19

No results posted yet for this study

Summary

The goal of this observational study is to clarify the clinical characteristics of autoimmune hepatitis (AIH) in China. The main questions it aims to answer are:

Human leukocyte antigen (HLA) gene susceptibility in Chinese AIH patients prognostic factors associated with AIH Participants will provide liver tests results and details of treatment during follow-up.

Conditions

  • Autoimmune Hepatitis

Sponsors & Collaborators

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Xinyan Zhao · Beijing Friendship Hospital

  • Zhengsheng Zou · Beijing 302 Hospital

  • Yu Chen · Beijing You 'an Hospital, Capital Medical University

  • Jia Li · Tianjin Second People's Hospital

  • Jingshou Chen · The First Affiliated Hospital of Xiamen University

  • Liang Wang · Lanzhou University Second Hospital

  • Huahua Wang · Jiaozuo People's Hospital

  • Xiaoli Hu · Heilongjiang Provincinal Hospital

  • Pingying Li · Qinghai People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2034-05-01
Completion
2034-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06356506 on ClinicalTrials.gov